Myoblast Autologous Grafting in Ischemic Cardiomyopathy - MAGIC

Description:

Preclinical studies have suggested that the implantation of contractile cells in the post-infarct myocardium could improve left ventricular (LV) function. This was the first clinical trial to address this issue, with the objective being to address the safety and efficacy of autologous skeletal myoblasts compared with a placebo injection in patients undergoing coronary artery bypass grafting (CABG) for multivessel coronary artery disease and severe LV dysfunction.